Clinical Trials Browser

Phase 3 × Withdrawn × 30 days × Clear all

NCT07551544 2026-05-19

ANKTIVA Plus BCG Versus BCG Monotherapy In Participants With BCG-Naïve/BCG-Exposed High-Grade Non-Muscle Invasive Papillary Bladder Cancer

Phase 3 Withdrawn

Non-Muscle Invasive Bladder Neoplasms